CRYOPORT, INC. Liabilities Assumed
CRYOPORT, INC. (CYRX) reported Liabilities Assumed of $165.99 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-04.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:LiabilitiesAssumed1 · last filed 2017-05-04
- CRYOPORT, INC. liabilities assumed for the quarter ending 2017-03-31 was $165.99K.
- CRYOPORT, INC. liabilities assumed for the quarter ending 2016-03-31 was $0.00.
- CRYOPORT, INC. liabilities assumed for the quarter ending 2015-12-31 was $0.00.
- CRYOPORT, INC. liabilities assumed for the quarter ending 2015-09-30 was $0.00.
| Period end | Liabilities Assumed 3 month | Liabilities Assumed 6 month | Liabilities Assumed 9 month | Liabilities Assumed 12 month |
|---|---|---|---|---|
| 2017-03-31 | $165.99K 10-Q · filed 2017-05-04 | |||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-04 | $0.00 derived: sum of 2 quarters · filed 2017-05-04 | $0.00 derived: sum of 3 quarters · filed 2017-05-04 | $0.00 derived: sum of 4 quarters · filed 2017-05-04 |
| 2015-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-11 | $0.00 derived: sum of 2 quarters · filed 2016-02-11 | $0.00 10-Q · filed 2016-02-11 | |
| 2015-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-11-16 | $0.00 10-Q · filed 2015-11-16 | ||
| 2015-06-30 | $0.00 10-Q · filed 2015-08-06 | |||
| 2014-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-11 | $0.00 derived: sum of 2 quarters · filed 2016-02-11 | $9.66K 10-Q · filed 2016-02-11 | |
| 2014-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-11-16 | $9.66K 10-Q · filed 2015-11-16 | ||
| 2014-06-30 | $9.66K 10-Q · filed 2015-08-06 | |||
| 2013-12-31 | $0.00 10-Q · filed 2015-02-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |